CLASS II Drug recall · Reported 31 May 2017 · FDA Enforcement Report

Estrone, For Prescription Compounding recalled by Fagron

Fagron is recalling Estrone, For Prescription Compounding, distributed nationwide in the US. The recall was initiated on 6 Apr 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #, Expiration Date: a) 16J05-U01-032346, 16G18-F003A, Exp. 5/17/2018; 16J25-U05-033898, Exp. 5/18/2018. b) 16F23-U04-031011, 16J05-U02-032345, 16G18-F003A, Exp. 5/17/2018; 16J25-U05-033897, 16J25-U05-034708, 16J25-U05-035527, Exp. 5/18/2018; c) 16F23-U04-031024, 16K16-U337-033665, 16G18-F003; 16G18-F003A, Exp. 5/17/2018. d) 16K16-U337-033664, 16G18-F003, Exp. 5/17/2018; 16J25-U05-034707, Exp. 5/18/2018.
Quantity recalled1313 grams

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0792-2017
FDA event ID
77060
Recalling firm
Fagron, Saint Paul, MN
Classification
Class II
Status
Terminated
Recall initiated
6 Apr 2017
FDA classified
19 May 2017
Reported
31 May 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter

Timeline

6 Apr 2017Recall initiated by company
19 May 2017Classified by FDA+43 days
31 May 2017Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

cGMP Deviations: lack of quality assurance at the API manufacturer.

Product as listed by the FDA

Estrone, For Prescription Compounding, packaged in a) 1 G bottle (NDC: 51552-0445-1), b) 5 G bottle (NDC 51552-0445-2), c) 25 G bottle (NDC: 51552-0445-4), d) 100 G bottle (NDC: 51552-0445-5), RX only, Distributed by Fagron, Inc. 2400 Pilot Knob Rd, St. Paul, MN 55120 Tel. 1-(800) 423-6967 Also packaged as: Estrone USP, For Prescription Compounding, packaged in a) 1 G bottle (NDC 52372-9494-01), b) 5 G bottle (NDC 52372-9494-05), c) 25 G bottle (NDC 52372-9494-03), d) 100 G bottle ( NDC 52372-9494-02), Rx only, Distributed by FREEDOM 801 W. New Orleans St. Broken Arrow, OK 74011 Tel. (877) 839-8547

Where it was distributed

Nationwide in US and PR and Australia

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

cGMP Deviations: lack of quality assurance at the API manufacturer.

Which lots are affected?

Lot #, Expiration Date: a) 16J05-U01-032346, 16G18-F003A, Exp. 5/17/2018; 16J25-U05-033898, Exp. 5/18/2018. b) 16F23-U04-031011, 16J05-U02-032345, 16G18-F003A, Exp. 5/17/2018; 16J25-U05-033897, 16J25-U05-034708, 16J25-U05-035527, Exp. 5/18/2018; c) 16F23-U04-031024, 16K16-U337-033665, 16G18-F003; 16G18-F003A, Exp. 5/17/2018. d) 16K16-U337-033664, 16G18-F003, Exp. 5/17/2018; 16J25-U05-034707, Exp. 5/18/2018.

Where was it sold?

Nationwide in US and PR and Australia

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 77060
ReportedClassRecallCompanyReasonWhere
CLASS IIEstriol, For Prescription Compounding recalled by FagronFagronManufacturing (CGMP) DeviationsNationwide

More recalls from Fagron

All 22